Similarly, armed oncolytic adenovirus expressing PD-L1 mini-body enhances the anti-tumor activity of HER2 CAR T cells in a HER2+ prostate cancer xenograft model [87]. This evidence concerns the gene ERBB2 and prostate cancer.